UBS Group’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-675
| Closed | -$1.36K | – | 9257 |
|
|
2024
Q3 | $1.36K | Sell |
675
-60
| -8% | -$121 | ﹤0.01% | 7439 |
|
|
2024
Q2 | $1.22K | Sell |
735
-392
| -35% | -$651 | ﹤0.01% | 7461 |
|
|
2024
Q1 | $6.81K | Sell |
1,127
-686
| -38% | -$4.14K | ﹤0.01% | 6261 |
|
|
2023
Q4 | $12.7K | Sell |
1,813
-1,856
| -51% | -$13K | ﹤0.01% | 6134 |
|
|
2023
Q3 | $32.1K | Sell |
3,669
-1,475
| -29% | -$12.9K | ﹤0.01% | 5432 |
|
|
2023
Q2 | $60.4K | Sell |
5,144
-47
| -0.9% | -$552 | ﹤0.01% | 5309 |
|
|
2023
Q1 | $88.9K | Buy |
5,191
+628
| +14% | +$10.8K | ﹤0.01% | 4922 |
|
|
2022
Q4 | $120K | Buy |
4,563
+659
| +17% | +$17.3K | ﹤0.01% | 4827 |
|
|
2022
Q3 | $396K | Buy |
3,904
+217
| +6% | +$22K | ﹤0.01% | 3562 |
|
|
2022
Q2 | $521K | Buy |
3,687
+405
| +12% | +$57.2K | ﹤0.01% | 3327 |
|
|
2022
Q1 | $518K | Sell |
3,282
-196
| -6% | -$30.9K | ﹤0.01% | 3731 |
|
|
2021
Q4 | $771K | Buy |
3,478
+286
| +9% | +$63.4K | ﹤0.01% | 3643 |
|
|
2021
Q3 | $616K | Buy |
3,192
+2,987
| +1,457% | +$576K | ﹤0.01% | 3591 |
|
|
2021
Q2 | $49K | Sell |
205
-32
| -14% | -$7.65K | ﹤0.01% | 5388 |
|
|
2021
Q1 | $81K | Sell |
237
-370
| -61% | -$126K | ﹤0.01% | 5134 |
|
|
2020
Q4 | $217K | Buy |
607
+560
| +1,191% | +$200K | ﹤0.01% | 4232 |
|
|
2020
Q3 | $22K | Sell |
47
-88
| -65% | -$41.2K | ﹤0.01% | 5388 |
|
|
2020
Q2 | $19K | Buy |
135
+59
| +78% | +$8.3K | ﹤0.01% | 5755 |
|
|
2020
Q1 | $7K | Buy |
76
+56
| +280% | +$5.16K | ﹤0.01% | 6254 |
|
|
2019
Q4 | $3K | Buy |
+20
| New | +$3K | ﹤0.01% | 6692 |
|